The commonly used and much maligned diabetes drug, Avandia, just took another spill down the stairs. A
new mouse study shows that the drug weakens bones and is likely to cause osteoporosis in the millions of users in the United States. The drug was shown to get directly in the way of healthy bone function, causing accelerated bone loss and slowed bone growth.
Read More: Avandia,
bone function,
GlaxoSmithKline,
heart disease,
osteoporosis
The common diabetes drugs Avandia and Actos are once again in the spotlight. This time, because they double the risk of fracture in women.
Read More: Actos,
Avandia,
Bone fracture risk,
heart failure
The simple fact that Avandia remains on the market is a testament to ongoing abysmal corruption at the FDA. The latest study is published in the British Medical Journal and concludes, "Our findings suggest clinically important differences in the cardiovascular safety profiles of rosiglitazone [Avandia] and pioglitazone (Actos] in clinical practice. Given the accumulating evidence of harm with rosiglitazone treatment and the lack of a distinct clinical advantage for the drug over pioglitazone, it is reasonable to question whether ongoing use of rosiglitazone is justified."
Read More: Avandia,
heart failure
Actos and Avandia shouldn’t even be on the market as they have already been proven to cause heart failure. Now it is clear they also cause abnormal bone fractures. People who are type II diabetic are already at increased risk for both of these problems anyway. Why on earth would they want to take a medication that increases the risk for both problems even further.
Read More: Actos,
Avandia,
Cardio Helper,
Daily Bone Xcel™,
Daily Builder™,
fractures,
Pantethine
It appears the new FDA leadership is not much different than the last administration, as the diabetes drug Avandia killed 304 people in the third quarter of 2009 while the FDA dragged its feet. The scandal is hitting a fever pitch as the
New York Times and
Washington Post feature stories on a bipartisan Senate investigatory report released over the weekend. It criticizes GlaxoSmithKline for failing to warn patients years earlier that Avandia was potentially deadly. “Instead, G.S.K. executives attempted to intimidate independent physicians, focused on strategies to minimize or misrepresent findings that Avandia may increase cardiovascular risk, and sought ways to downplay findings that a competing drug might reduce cardiovascular risk,” concludes the report, which was overseen by Senator Max Baucus, a Montana Democrat, and Senator Charles E. Grassley, an Iowa Republican.
Read More: Avandia,
Cardio Helper,
cardiovascular risk,
Cinnamon Plus™,
Daily Balancer™,
Daily Protein Plus™,
FDA,
Fiber Helper™,
GlaxoSmithKline,
Gluco Plus™,
LeptiCardio Pack™,
Leptin Control Pack®,
Leptinal®,
LeptiSlim®,
Stress Helper®
The often-prescribed diabetic medications Avandia and Actos have now been proven to cause an increase risk in fractures in postmenopausal women. In men if these drugs are combined with a potassium-robbing diuretic, then the fracture risk is also increased. The FDA is currently considering whether to remove Avandia from the market because it causes heart attacks. Actos is eqally as risky as Avandia in regard to fracture, but it has not proven as dangerous as Avandia with heart attack concerns. This is the third time these researchers have published conclusive data on this risk — and the FDA twiddles its thumbs.
Read More: Actos,
Avandia,
Bone fracture risk,
FDA,
metabolism,
postmenopausal
The thiazolidinedione diabetes drugs Avandia and Actos will break your bones and cause heart failure. DHA will help preserve your bones and rejuvenate your heart’s function. They all activate PPAR gamma. Understanding why the drugs are so dangerous and why the nutrient is so helpful is a prime example of why nutrition excels at restoring damaged metabolism and drugs are a fast track to a number-manipulating nowhere.
Read More: Actos,
Avandia,
DHA,
genes,
HDL cholesterol,
insulin,
metabolism,
overweight,
PPAR gamma,
Triglycerides
The more we learn about genes the more obvious it becomes that nutrition is the key to health, including bone health. A gene regulatory protein called Maf has now been identified which is needed in order to change bone stem cells into the important bone-building carpenters called osteoblasts. Too many free radicals, or the use of the diabetes drugs Avandia or Actos, causes Maf to turn off. This causes the stem cells to turn into fat cells instead of osteoblasts, causing bone loss and risk for osteoporosis.
Read More: antioxidants,
Avandia,
bone loss,
free radicals,
osteoporosis
2010 is a year marked by an explosion in gene-related nutritional science, with significant findings to improve the health of one and all. In contrast, the same type of gene science applied to the function of commonly used drugs is showing their true colors. These toxic poisons should be avoided for all but the most desperate use in true medical situations. They should absolutely never be used for preventive health or the management of symptoms or numbers.
Read More: Actos,
alzeimher's prevention,
Avandia,
blood pressure medication,
blood sugar,
Blueberries,
brain function,
DHA,
friendly flora,
GMO,
gum problems,
health freedom,
mental illness,
pH balance,
sugar,
Vitamin E